Frequency Therapeutics - Stock Price History | FREQ

Historical daily share price chart and data for Frequency Therapeutics since 2021 adjusted for splits. The latest closing stock price for Frequency Therapeutics as of September 27, 2021 is 7.49.
  • The all-time high Frequency Therapeutics stock closing price was 55.01 on February 19, 2021.
  • The Frequency Therapeutics 52-week high stock price is 58.37, which is 679.3% above the current share price.
  • The Frequency Therapeutics 52-week low stock price is 6.65, which is 11.2% below the current share price.
  • The average Frequency Therapeutics stock price for the last 52 weeks is 20.71.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Frequency Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 21.8983 17.2200 40.0000 14.6500 35.2600 101.14%
2019 15.5567 13.7000 18.7300 12.6700 17.5300 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.258B $0.037B
Frequency Therapeutics Inc. is a clinical-stage biotechnology company. It is focused on harnessing the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. The company's lead product candidate, FX-322, is in clinical development and is designed to regenerate auditory hair cells to restore hearing function in patients with sensorineural hearing loss. Frequency Therapeutics Inc. is headquartered in Woburn, Mass.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29